
Dodecyl methyl sulfide | CAS:3698-89-3
Dodecyl methyl sulfide
- 名称:正十二烷基甲基硫醚 | Dodecyl methyl sulfide
- CAS号:3698-89-3
- 别名:
- 分子式:C13H28S
- 分子量:216.43
- EINESC号:223-028-7
产品描述
物理化学性质
沸点 | 110 ºC (0.2 mmHg) |
---|---|
闪点 | 110 ºC |
密度 | 0.816 |
折射率 | 1.4610 |
安全数据
没有数据 | 没有数据 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.T Klopstock et al.Brain : a journal of neurology, 136(Pt 2), e230-e230 (2013-02-08)
Idebenone-induced recovery of glycerol-3-phosphate and succinate oxidation inhibited by digitonin.H Rauchová et al.Physiological research, 61(3), 259-265 (2012-04-07)
Monogenic mitochondrial disorders.Werner J H Koopman et al.The New England journal of medicine, 366(12), 1132-1141 (2012-03-23)
Co-enzyme Q10 and idebenone use in Friedreich's ataxia.Michael H Parkinson et al.Journal of neurochemistry, 126 Suppl 1, 125-141 (2013-07-24)
Clinical experience with high-dose idebenone in Friedreich ataxia.Jörg B Schulz et al.Journal of neurology, 256 Suppl 1, 42-45 (2009-04-11)
In vitro evaluation on a model of blood brain barrier of idebenone-loaded solid lipid nanoparticles.L Montenegro et al.Journal of nanoscience and nanotechnology, 12(1), 330-337 (2012-04-25)
Idebenone - monograph. Alternative medicine review : a journal of clinical therapeutic, 6(1), 83-86 (2001-02-24)
Idebenone: a review in Leber?s hereditary optic neuropathyLyseng-Williamson KA Drugs, 76(7), 805-813 (2016)
Pharmacokinetic evaluation of idebenone.Claudia Becker et al.Expert opinion on drug metabolism & toxicology, 6(11), 1437-1444 (2010-10-20)
Effects of cytoprotective antioxidants on lymphocytes from representative mitochondrial neurodegenerative diseases.Ruth Goldschmidt et al.Bioorganic & medicinal chemistry, 21(4), 969-978 (2013-01-15)
Inhibition of brain mitochondrial swelling by idebenone.M Suno et al.Archives of gerontology and geriatrics, 8(3), 299-305 (1989-05-01)
Prevention of gentamicin-induced apoptosis with the mitochondria-targeted antioxidant mitoquinone.Carolyn P Ojano-Dirain et al.The Laryngoscope, 122(11), 2543-2548 (2012-09-12)
Idebenone treatment mediates the effect of menadione oxidative stress damage in Saccharomyces cerevisiae.Oliver Gamondi et al.Drug metabolism letters, 6(2), 120-123 (2012-09-15)
Chemical and technological delivery systems for idebenone: a review of literature production.Claudia Carbone et al.Expert opinion on drug delivery, 9(11), 1377-1392 (2012-10-23)
2-deoxy-D-glucose enhances anesthetic effects in mice.Hui Wang et al.Anesthesia and analgesia, 120(2), 312-319 (2014-11-13)
Determination of idebenone in plasma by HPLC with post-column fluorescence derivatization using 2-cyanoacetamide.Yukio Nohara et al.Chemical & pharmaceutical bulletin, 60(5), 598-602 (2012-06-13)
Idebenone and coenzyme Q10 are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases.Jens Tiefenbach et al.Disease models & mechanisms, 11(9) (2018-09-02)
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.Sebastian M Fiebiger et al.Journal of neuroimmunology, 262(1-2), 66-71 (2013-07-23)
Idebenone in Friedreich's ataxia.Caterina Tonon et al.Expert opinion on pharmacotherapy, 9(13), 2327-2337 (2008-08-20)
Is Leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case.Esfandiar J Sabet-Peyman et al.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 32(1), 54-57 (2012-01-25)
A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.Daniel Kiblboeck et al.BMJ case reports, 2012, doi:10-doi:10 (2012-08-29)
Idebenone and reduced cardiac hypertrophy in Friedreich's ataxiaHausse AO, et al. Heart, 87(4), 346-349 (2002)
Idebenone treatment in patients with OPA1-mutant dominant optic atrophy.Piero Barboni et al.Brain : a journal of neurology, 136(Pt 2), e231-e231 (2013-02-08)
Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone.Bei Li et al.AAPS PharmSciTech, 13(1), 276-283 (2012-01-12)
Primary and secondary drug screening assays for Friedreich ataxiaCotticelli MG, et al. Journal of Biomolecular Screening, 17(3), 303-313 (2012)
Idebenone and coenzyme Q10 are novel PPAR alpha gamma ligands, with potential for treatment of fatty liver diseasesTiefenbach J, et al. Disease models & mechanisms, 11(9), dmm034801-dmm034801 (2018)
Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.Caterina Mariotti et al.Movement disorders : official journal of the Movement Disorder Society, 27(3), 446-449 (2012-03-14)
[Synthesis and biochemical actions of idebenone and related compounds. Ubiquinone and related compounds, XL].H Morimoto Die Naturwissenschaften, 76(5), 200-205 (1989-05-01)
Mitochondrial optic neuropathies: our travels from bench to bedside and back again.Alfredo A Sadun et al.Clinical & experimental ophthalmology, 41(7), 702-712 (2013-02-26)
Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I.Michael Erb et al.PloS one, 7(4), e36153-e36153 (2012-05-05)
Idebenone loaded solid lipid nanoparticles interact with biomembrane models: calorimetric evidence.Lucia Montenegro et al.Molecular pharmaceutics, 9(9), 2534-2541 (2012-08-17)
Idebenone, green tea, and Coffeeberry extract: new and innovative antioxidants.Patricia Farris Dermatologic therapy, 20(5), 322-329 (2007-11-30)
Visual improvement with the use of idebenone in the treatment of Wolfram syndrome.Simon R Bababeygy et al.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 32(4), 386-389 (2012-12-01)
Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.Fabrice D Heitz et al.PloS one, 7(9), e45182-e45182 (2012-10-03)
Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders.J C Gillis et al.Drugs & aging, 5(2), 133-152 (1994-08-01)
Idebenone: an emerging therapy for Friedreich ataxia.Thomas Meier et al.Journal of neurology, 256 Suppl 1, 25-30 (2009-04-11)
Treatment of Leber hereditary optic neuropathy.Nancy J Newman Brain : a journal of neurology, 134(Pt 9), 2447-2450 (2011-08-24)
Idebenone maintains survival of mutant myocilin cells by inhibiting apoptosisGuan Y, et al. Chinese Medicine, 129(16), 2001-2001 (2016)
Antioxidants and other pharmacological treatments for Friedreich ataxia.Mary Kearney et al.The Cochrane database of systematic reviews, 4(4), CD007791-CD007791 (2012-04-20)
The effects of idebenone on mitochondrial bioenergetics.Valentina Giorgio et al.Biochimica et biophysica acta, 1817(2), 363-369 (2011-11-17)
Effects of idebenone on color vision in patients with leber hereditary optic neuropathy.Guenther Rudolph et al.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 33(1), 30-36 (2012-12-25)
Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.Vanna Geromel et al.Molecular genetics and metabolism, 77(1-2), 21-30 (2002-10-03)
Exonic deletions of FXN and early-onset Friedreich ataxia.Mathieu Anheim et al.Archives of neurology, 69(7), 912-916 (2012-03-14)
Idebenone-loaded solid lipid nanoparticles for drug delivery to the skin: in vitro evaluation.Lucia Montenegro et al.International journal of pharmaceutics, 434(1-2), 169-174 (2012-06-05)
[The use of idebenone (noben) in neurological practice].I V Damulin Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 106(11), 66-71 (2006-12-21)
Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice.Ellen Gerhardt et al.PloS one, 6(12), e28855-e28855 (2011-12-30)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!